The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Clarithromycin 500 mg Powder for concentrate for solution for infusion

Noridem Enterprises LimitedPA1122/025/001

Main Information

Trade NameClarithromycin 500 mg Powder for concentrate for solution for infusion
Active SubstancesClarithromycin lactobionate
Dosage FormPowder for concentrate for solution for infusion
Licence HolderNoridem Enterprises Limited
Licence NumberPA1122/025/001

Group Information

ATC CodeJ01FA09 clarithromycin


License statusAuthorised
Licence Issued22/03/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back